Trial Profile
Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Asparaginase (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Sponsors Medac
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Planned End Date changed from 1 Mar 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 19 Nov 2008 New trial record.